Earnings call · Apr–Jun 2026
PI Industries Limited
Apr–Jun 2026 revenue was ₹1,702 crore with 57% gross margin & 22% EBITDA margin. Domestic volumes grew 12% despite delayed sowing; biologicals surged 50%. Management expects FY27 to be better than FY26 with recovery in exports & new product launches.
The full notes: the guidance, numbers & KPIs, strategy, outlook, risks, what analysts asked.
Premium opens every call in full: the notes, the marked passages, search & topic jumps, for every company that files a transcript.
From the company
- Mayank Singhal
- Sanjay Agarwal
- Abhijit Akella
- Anand Jain
- Jagresh Rana
Questions came from
- Ankur PeriwalAxis Capital
- Tejas PradhanCiti Group
- Rohit Nagraj360 ONE Capital
- Surya Narayan PatraPhillip Capital India
- Sanjay Kumar
- RijuAntique Stock Broking
- Siddharth GadekarEquirus
Hosted by Nishid Solanki of CDR India
Topics in this call
Opening remarks
Mayank Singhal
Thanks. Good afternoon, everyone and thank you for joining the call today. I will share few perspectives on the agrochemical industry dynamics followed by PI’s performance and progress on new strategic initiatives.
The global crop protection market is showing early signs of demand and stabilization. While geopolitical and energy-related disruptions have moderated, the need for resilient supply chains and diversification has been reinforced. This environment plays directly into PI's strengths as a research and technology leader with unique proposition of long trusted partnerships.
Read the whole call: 182 paragraphs, 7 analysts' questions with every answer, 10 marked passages.
Premium opens every call in full: the notes, the marked passages, search & topic jumps, for every company that files a transcript.
The transcript as the company filed it on BSE. Our own rules split it into speakers & sections; an unusual layout can trip them, so check the original PDF for anything important. Not a recommendation.